Financial Summary (All financials)
In millions, except per share items | Mar-31-23 | Mar-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
Revenues | 17,026 | 18,317 | 18,657 | 19,352 | 20,279 |
Revenue growth | -7.0% | | -3.6% | -4.6% | |
Cost of goods sold | 14,498 | 16,057 | 16,570 | 17,143 | 17,682 |
Gross profit | 2,528 | 2,260 | 2,087 | 2,209 | 2,597 |
Gross margin | 14.8% | 12.3% | 11.2% | 11.4% | 12.8% |
Selling, general and administrative | 2,914 | 2,752 | 2,776 | 2,948 | 2,970 |
EBITA | -676 | -1,541 | -651 | -710 | -344 |
EBITA margin | -4.0% | -8.4% | -3.5% | -3.7% | -1.7% |
Amortization of intangibles | 46 | 37 | 37 | 29 | 29 |
EBIT | -722 | -1,578 | -688 | -739 | -373 |
EBIT margin | -4.2% | -8.6% | -3.7% | -3.8% | -1.8% |
Pre-tax income | -851 | -1,689 | -1,922 | -1,766 | -579 |
Income taxes | 524 | 350 | 397 | 246 | 364 |
Net income | -1,374 | -2,039 | -2,319 | -2,011 | -943 |
Net margin | -8.1% | -11.1% | -12.4% | -10.4% | -4.7% |
|
Diluted EPS | ($6.06) | ($9.09) | ($10.35) | ($8.97) | ($4.21) |
Shares outstanding (diluted) | 227 | 224 | 224 | 224 | 224 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|